Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Expanded Access Program:Lenalidomide With or Without Dexamethasone In Previously Treated Subjects With Multiple Myeloma

ClinicalTrials.gov ID: NCT00179647

Public ClinicalTrials.gov record NCT00179647. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 7:58 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Single-Arm, Open-Label, Expanded Access Program for Lenalidomide With or Without Dexamethasone in Previously Treated Subjects With Multiple Myeloma

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Subjects who qualify for participation will receive lenalidomide with or without dexamethasone in 4 week cycles until disease progression is documented or lenalidomide becomes commercially available for the indication of multiple myeloma.

Study identification

NCT ID
NCT00179647
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Celgene Corporation
Industry
Enrollment
1,913 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 2005 (Type not available)
Primary completion
Dec 2008 (Actual)
Completion
Apr 2009 (Actual)
Last update posted
Mar 16, 2010

2005 – 2009

United States locations

U.S. sites
63
U.S. states
34
U.S. cities
57
Facility City State ZIP Site status
Mayo Clinic Scottsdale Arizona 85259 —
Alta Bates Cancer Center Berkeley California 94704 —
Scripps Cancer Center La Jolla California 93037 —
Cedar Sinai Medical CenterDept of Medicine Los Angeles California 90048 —
Kaiser Permanente Medical Group San Diego California 32120 —
Stanford Cancer Center Stanford California 94305-5750 —
Kaiser Permanente Medical Center Vallejo California 94589 —
University of ColoradoHealth Science Center Aurora Colorado 80045-0510 —
Rocky Mountain Cancer Center-Midtown Denver Colorado 80218 —
Yale University School of Medicine New Haven Connecticut 06520 —
Hematology Oncology, PC Stamford Connecticut 06902 —
Delaware Clinical & Laboratory Physicians, PA Newark Delaware 19713 —
University of Miami Medical School Miami Florida 33136 —
Mount Sinai Comprehensive Cancer Center Miami Beach Florida 33140 —
Gulf Coast Oncology St. Petersburg Florida 33705 —
H Lee Moffitt Cancer Center Tampa Florida 33612-9497 —
The Palm Beach Cancer Institute West Palm Beach Florida 33401 —
Emory University Atlanta Georgia 30322 —
Northwestern University Med CtrDivision of Hem/Onc Chicago Illinois 60611-2927 —
Rush Cancer Institute Chicago Illinois 60612-3824 —
Indiana Univ Cancer Center Bone Marrow Transplantation Program Indiana Cancer Research Institute Indianapolis Indiana 46202-5254 —
University of Kansas Medical Center Kansas City Kansas 66160-7233 —
Wichita CCOP Wichita Kansas 67214 —
Ochsner Clinic Foundation New Orleans Louisiana 70121 —
University of Maryland Medical Center Greenbaum Cancer Ctr Baltimore Maryland 21201-1595 —
Center for Cancer And Blood Disorders Bethesda Maryland 20817 —
Dana-Farber Cancer Institute Boston Massachusetts 02115 —
Mayo Clinic Cancer Center Rochester Minnesota 55905 —
Jackson Oncology Associates Jackson Mississippi 39202 —
Siteman Cancer Center St Louis Missouri 63110 —
Deaconess Billings Clinic Billings Montana 59102 —
Methodist Cancer Center Omaha Nebraska 68114 —
Nevada Cancer Center Las Vegas Nevada 89109 —
Dartmouth Hitchcock Medical Center-Norris Cotton Cancer Center Lebanon New Hampshire 03756 —
The Cancer Center at Hackensack University Medical Center Hackensack New Jersey 07601 —
SUNY Health Science Center - Brooklyn Brooklyn New York 11203 —
North Shore Hematology/Oncology Associates, PC East Setauket New York 11733 —
St. Vincent's Comprehensive Cancer Center New York New York 10011 —
NY Presbyterian Hospital/Weill Medical College-Cornell University New York New York 10021 —
SUNY Upstate Medical University Syracuse New York 13210 —
New York Medical Center, MBCCOP The Bronx New York 10466 —
Carolinas Hematology-Oncology Associates Charlotte North Carolina 28203 —
Wake Forest University School of Medicine Winston-Salem North Carolina 27157-1023 —
Dakota Cancer Institute Fargo North Dakota 58108-6001 —
Mid Ohio Oncology & Hematology, Inc. Columbus Ohio 43215 —
Kaiser Permanente Northwest RegionCenter for Health Research Portland Oregon 97227 —
University of Pennsylvania Cancer Center Philadelphia Pennsylvania 19104 —
Western Pennsylvania Cancer Institute Pittsburgh Pennsylvania 15224 —
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15232 —
Charleston Hematology/Oncology P.A. Charleston South Carolina 29403 —
Medical University of South Carolina Charleston South Carolina 29425 —
South Carolina Oncology Assoc Columbia South Carolina 29210 —
Avera Research Institute Sioux Falls South Dakota 57105 —
University of Texas Southwestern Medical Center Dallas Texas 75390-9016 —
MD Anderson Cancer Center Houston Texas 77030 —
Huntsman Cancer Institute Salt Lake City Utah 84112 —
Intermountain Hematology/Oncology Salt Lake City Utah 84124 —
Medical College of Virginis, North Hospital Richmond Virginia 23298 —
Swedish Cancer Institute Seattle Washington 98104 —
Fred Hutchinson Cancer Research Center Seattle Washington 98109 —
Gunderson Clinic La Crosse Wisconsin 54601 —
Marshfield Clinic Marshfield Wisconsin 54449 —
Oncology Alliance Milwaukee Wisconsin 53215 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00179647, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 16, 2010 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00179647 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →